PWAs closer to drug access

Health Canada, bowing to public pressure, approved a clinical trial of the experimental AIDS therapy drugs sought by six Vancouver people, Dec 20.

“I’d say we had a partial success,” says one of the patients, BC Persons With AIDS Society chair Paul Lewand. “Hopefully within a month, the drugs will be available for five of the six people who needed them.” One person died waiting.

“There is all sorts of good news about this,” says Lewand. “We worked really hard to make something happen and something did happen. Just not everything we wanted.”

Lewand says only the five surviving patients will get access for now.

Lewand’s physician, world-renowned HIV/AIDS specialist Dr Julio Montaner, wanted the drugs approved for use under a compassionate care program, but Health Canada said the drugs are not eligible because they haven’t yet been proved safe for humans. Instead they approved a clinical trial of the drugs.

“I trust Dr Montaner completely,” says Lewand, and he says Montaner has assured him the trial will proceed as quickly as possible. But, asks Lewand, “How can you do a legitimate clinical trial for five people? It doesn’t really make sense. There can be no placebo given to half the group.”

Keep Reading

What you need need to know about gender-affirming care for youth

What sort of healthcare is available? Do parents have any say? Is the healthcare safe and effective?

Could this week’s Supreme Court abortion pill case affect gender-affirming care?

OPINION: The Comstock Act, a 150-year-old federal obscenity law, has advocates on edge

Raising the bar: How an Edmonton gym is making exercise accessible

Run by queer and trans professionals, Action Potential Fitness was created with LGBTQ2S+ clients in mind
The Ohio state legislature building with a blue star with stars and stripes behind it.

Ohio’s trans healthcare ban sets dangerous precedent ahead of 2024 election

ANALYSIS: Ohio has set a new precedent for using gubernatorial powers to indirectly outlaw transition—other states may follow